Broschiertes Buch

Volociximab

Versandkostenfrei!

Versandfertig in 6-10 Tagen

23,99 €

inkl. MwSt.

Jetzt bewerten

PAYBACK Punkte

12 °P sammeln!

High Quality Content by WIKIPEDIA articles! Volociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma and Biogen Idec for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of 5 1 integrin.Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by one type of immune cell that are all clones of a unique parent cell.